Where does NeXtGen Biologics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NeXtGen Biologics's 2 recorded funding rounds.

Premier Alternatives

NeXtGen Biologics

Alachua, FL · Founded 2014 · Privately Held (backing)

Developer of extracellular matrix biomaterial products designed to harness axolotl-derived extracellular matrix components for tissue regeneration. NeXtGen Biologics is based in Alachua, FL and was founded in 2014. Its last reported valuation was $6.6 million in Nov 2015. It has raised $6.7 million across 2 recorded rounds; the latest was a $2.2 million seed round in Dec 2018.

Last reported valuation

$6.6M

Oct 2026

Priced at

—

Total raised

$6.7M

Last round

Seed Round

Dec 2018

Cap table — not yet on record

NeXtGen Biologics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of NeXtGen Biologics with a free account

·Watch NeXtGen Biologics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about NeXtGen Biologics

Where does NeXtGen Biologics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NeXtGen Biologics's 2 recorded funding rounds.